Should we apply?
7 questions about Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional). The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.